S R Gillett1, L A McClure2, P W Callas1, E L Thacker3, F W Unverzagt4, V G Wadley5, A J Letter6, M Cushman1. 1. Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA. 2. Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, PA, USA. 3. Department of Health Science, Brigham Young University, Provo, UT, USA. 4. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. 5. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 6. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract
Essentials Cognitive disorders are increasing and vascular risk factors play a role in this. We performed a nested case control study of hemostasis biomarkers and cognitive impairment (CI). Higher baseline fibrinogen, factor VIII and D-dimer were related to incident CI over 3.5 years. Adjusted for other risk factors, 2+ abnormal markers (but not single ones) led to higher risk. SUMMARY: Background Vascular risk factors are associated with cognitive impairment, a condition that imposes a substantial public health burden. We hypothesized that hemostasis biomarkers related to vascular disease would be associated with the risk of incident cognitive impairment. Methods We performed a nested case-control study including 1082 participants with 3.5 years of follow-up in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a longitudinal cohort study of 30 239 black and white Americans aged ≥ 45 years. Participants were free of stroke or cognitive impairment at baseline. Baseline D-dimer, fibrinogen, factor VIII and protein C levels were measured in 495 cases who developed cognitive impairment during follow-up (based on abnormal scores on two or more of three cognitive tests) and 587 controls. Results Unadjusted odds ratios (ORs) for incident cognitive impairment were 1.32 (95% confidence interval [CI] 1.02-1.70) for D-dimer > 0.50 μg mL-1 , 1.83 (95% CI 1.24-2.71) for fibrinogen > 90th percentile, 1.63 (95% CI 1.11-2.38) for FVIII > 90th percentile, and 1.10 (95% CI 0.73-1.65) for protein C < 10th percentile. There were no differences in associations by race or region. Adjustment for demographic, vascular and health behavior risk factors attenuated these associations. However, having at least two elevated biomarkers was associated with incident cognitive impairment, with an adjusted OR of 1.73 (95% CI 1.10-2.69). Conclusion Elevated D-dimer, fibrinogen and FVIII levels were not associated with the occurrence of cognitive impairment after multivariable adjustment; however, having at least two abnormal biomarkers was associated with the occurrence of cognitive impairment, suggesting that the burden of these biomarkers is relevant.
EssentialsCognitive disorders are increasing and vascular risk factors play a role in this. We performed a nested case control study of hemostasis biomarkers and cognitive impairment (CI). Higher baseline fibrinogen, factor VIII and D-dimer were related to incident CI over 3.5 years. Adjusted for other risk factors, 2+ abnormal markers (but not single ones) led to higher risk. SUMMARY: Background Vascular risk factors are associated with cognitive impairment, a condition that imposes a substantial public health burden. We hypothesized that hemostasis biomarkers related to vascular disease would be associated with the risk of incident cognitive impairment. Methods We performed a nested case-control study including 1082 participants with 3.5 years of follow-up in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a longitudinal cohort study of 30 239 black and white Americans aged ≥ 45 years. Participants were free of stroke or cognitive impairment at baseline. Baseline D-dimer, fibrinogen, factor VIII and protein C levels were measured in 495 cases who developed cognitive impairment during follow-up (based on abnormal scores on two or more of three cognitive tests) and 587 controls. Results Unadjusted odds ratios (ORs) for incident cognitive impairment were 1.32 (95% confidence interval [CI] 1.02-1.70) for D-dimer > 0.50 μg mL-1 , 1.83 (95% CI 1.24-2.71) for fibrinogen > 90th percentile, 1.63 (95% CI 1.11-2.38) for FVIII > 90th percentile, and 1.10 (95% CI 0.73-1.65) for protein C < 10th percentile. There were no differences in associations by race or region. Adjustment for demographic, vascular and health behavior risk factors attenuated these associations. However, having at least two elevated biomarkers was associated with incident cognitive impairment, with an adjusted OR of 1.73 (95% CI 1.10-2.69). Conclusion Elevated D-dimer, fibrinogen and FVIII levels were not associated with the occurrence of cognitive impairment after multivariable adjustment; however, having at least two abnormal biomarkers was associated with the occurrence of cognitive impairment, suggesting that the burden of these biomarkers is relevant.
Authors: Snorri Rafnsson; Ian J Deary; Martha C Whiteman; Ann Rumley; G D O Lowe; F Gerry R Fowkes Journal: Age Ageing Date: 2010-01-21 Impact factor: 10.668
Authors: Virginia J Howard; Dawn O Kleindorfer; Suzanne E Judd; Leslie A McClure; Monika M Safford; J David Rhodes; Mary Cushman; Claudia S Moy; Elsayed Z Soliman; Brett M Kissela; George Howard Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: Sarah R Gillett; Rebekah H Boyle; Neil A Zakai; Leslie A McClure; Nancy S Jenny; Mary Cushman Journal: Clin Biochem Date: 2014-08-14 Impact factor: 3.281
Authors: C P Cannon; C H McCabe; C M Gibson; M Ghali; R F Sequeira; G R McKendall; J Breed; N B Modi; N L Fox; R P Tracy; T W Love; E Braunwald Journal: Circulation Date: 1997-01-21 Impact factor: 29.690
Authors: P L Lutsey; M Cushman; L M Steffen; D Green; R G Barr; D Herrington; P Ouyang; A R Folsom Journal: J Thromb Haemost Date: 2006-09-26 Impact factor: 5.824
Authors: Snorri B Rafnsson; Ian J Deary; Felicity B Smith; Martha C Whiteman; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes Journal: J Am Geriatr Soc Date: 2007-05 Impact factor: 5.562
Authors: Mary Cushman; Leslie A McClure; Virginia J Howard; Nancy S Jenny; Susan G Lakoski; George Howard Journal: Clin Chem Date: 2009-07-30 Impact factor: 8.327
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Hyung Jin Ahn; J Fraser Glickman; Ka Lai Poon; Daria Zamolodchikov; Odella C Jno-Charles; Erin H Norris; Sidney Strickland Journal: J Exp Med Date: 2014-05-12 Impact factor: 14.307
Authors: Fred Stephen Sarfo; Rufus Akinyemi; George Howard; Virginia J Howard; Kolawole Wahab; Mary Cushman; Deborah A Levine; Adesola Ogunniyi; Fred Unverzagt; Mayowa Owolabi; Bruce Ovbiagele Journal: J Neurol Sci Date: 2020-02-19 Impact factor: 4.553
Authors: Thomas M Piers; Emma East; Claudio Villegas-Llerena; Ioanna G Sevastou; Mar Matarin; John Hardy; Jennifer M Pocock Journal: Front Cell Neurosci Date: 2018-11-19 Impact factor: 5.505
Authors: Jessica L Rohmann; W T Longstreth; Mary Cushman; Annette L Fitzpatrick; Susan R Heckbert; Kenneth Rice; Frits R Rosendaal; Colleen M Sitlani; Bruce M Psaty; Bob Siegerink Journal: PLoS One Date: 2020-11-16 Impact factor: 3.240